CHINA ORAL IND (08406) announced its interim results, reporting a net loss of 10.986 million yuan, turning from profit to loss compared to the same period last year.
China Oral Industry (08406) announced its interim results for the six months ending June 30, 2026, recording revenue of 74.247 million yuan, a year-on-year decrease of 32.05%; a net loss of 10.986 million yuan, compared to a profit of 4.069 million yuan in the same period last year; and a loss per share of 0.73 yuan.
CHINA ORAL IND (08406) announced its interim results for the six months ended June 30, 2026, with the group achieving revenue of 74.247 million yuan, a decrease of 32.05% year-on-year; a net loss of 10.986 million yuan, compared to a profit of 4.069 million yuan in the same period last year; and a loss of 0.73 per share.
Related Articles
CMGE (00302) announced its interim results, reporting a loss attributable to shareholders of 90.155 million yuan, a decrease of 85.9% year-on-year.
SAIMO (02571) announced its interim results, reporting a loss attributable to shareholders of 48.049 million yuan, a year-on-year shift from profit to loss.
DEXIN SER GROUP (02215) announced its interim results, with a profit attributable to shareholders of 30.465 million yuan, a year-on-year decrease of 10.76%.
CMGE (00302) announced its interim results, reporting a loss attributable to shareholders of 90.155 million yuan, a decrease of 85.9% year-on-year.
SAIMO (02571) announced its interim results, reporting a loss attributable to shareholders of 48.049 million yuan, a year-on-year shift from profit to loss.
DEXIN SER GROUP (02215) announced its interim results, with a profit attributable to shareholders of 30.465 million yuan, a year-on-year decrease of 10.76%.
RECOMMEND
